Seneca Biopharma Accounts Payable

Seneca Biopharma (SNCA) currently reports a accounts payable of $650K as of December 2020. That compares with $820K in the prior-year period — down 21.2% year over year. Use the charts on this page to explore Seneca Biopharma's accounts payable history and peer comparisons.

Seneca Biopharma's accounts payable decreased from $820K to $650K — a 21.2% year-over-year decrease (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Seneca Biopharma reported $650K in accounts payable as of December 2020. That compares with $820K in the prior-year period — down 21.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $650K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Seneca Biopharma, and consider following SNCA for alerts when major investors trade the stock.

Seneca Biopharma is classified in the Healthcare sector. On accounts payable, it currently shows $650K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SNCA with unrelated industries.